GlassScriptPhysician profile
Caitlyn Zinn
NPI 1952798092
$624.19
in general payments reported to CMS, 2019-2025
15 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.89 · 2022: $168 · 2023: $134 · 2024: $154 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $128.13 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $79.23 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $71.58 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $47.56 | 2022-2024 | |
| Exeltis, USA INC. | $44.26 | 2024-2025 | Slynd |
| Abbvie INC. | $43.60 | 2020-2022 | |
| Coopersurgical, INC. | $43.27 | 2023-2024 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Conmed Corporation | $28.18 | 2023 | Airseal |
| Myovant Sciences INC. | $24.14 | 2022 | |
| Pfizer INC. | $22.46 | 2023 | |
| Shield Therapeutics INC | $21.60 | 2023 | Accrufer |
| Exact Sciences Corporation | $21.27 | 2025 | Cologuard Collection Kit |
| Millicent US INC | $18.88 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $17.94 | 2020 | |
| Minerva Surgical, INC | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlyn Zinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.